Send Enquiry

PRIMA
Syrup
Packaging and packing Type
| 60ml
MRP :
₹132
PTR :
₹100.57
PTS :
₹90.51
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Read our full guide: Cefpodoxime: uses, dose, side effects and brands
Odoxicef CV WFR Dry Syrup is a dry syrup from Vibcare Pharma. It contains Cefpodoxime 50 mg and Clavulanic Acid 31.25 mg, and it belongs to the antibiotic and anti-infective (antibacterial) class. The pack is 60ml. This product comes from Vibcare Pharma's Prima division.
Cefpodoxime is a cephalosporin antibiotic. It works by damaging the cell wall of susceptible bacteria, so the bacteria are unable to survive. Clavulanic Acid is a beta-lactamase inhibitor. It blocks the resistance enzymes that some bacteria produce, which allows the antibiotic to carry on working against them.
This syrup is used for mild to moderate bacterial infections caused by susceptible organisms, such as acute otitis media, pharyngitis and tonsillitis, community-acquired pneumonia and acute bacterial exacerbation of chronic bronchitis. Significant or persistent diarrhoea, during or after treatment, should be reported to a doctor.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Odoxicef CV WFR Dry Syrup is used for bacterial infections of the ear, throat, lungs and airways. Main uses: acute otitis media (middle ear infection) caused by susceptible bacteria; pharyngitis and/or tonsillitis caused by susceptible bacteria; community-acquired pneumonia caused by susceptible bacteria; acute bacterial exacerbation of chronic bronchitis caused by susceptible bacteria.
Common side effects of Odoxicef CV WFR Dry Syrup include diarrhoea or loose stools; nausea; vomiting; headache; abdominal pain; vaginal or vulvovaginal infection. Get medical help at once if you notice severe allergic reactions, including anaphylaxis; severe skin reactions; clostridioides difficile-associated diarrhoea.
Odoxicef CV WFR Dry Syrup contains Clavulanic Acid 31.25 mg + Cefpodoxime 50 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Odoxicef CV WFR Dry Syrup only as your doctor advises.
The MRP of Odoxicef CV WFR Dry Syrup is ₹132 for a pack of 60ml. For chemists and distributors, the PTR is ₹100.57 and the PTS is ₹90.51.
Odoxicef CV WFR Dry Syrup contains Clavulanic Acid 31.25 mg + Cefpodoxime 50 mg. It comes in a pack of 60ml.
Cefpodoxime is a cephalosporin antibiotic. It works by damaging the cell wall of susceptible bacteria, so the bacteria are unable to survive. Clavulanic Acid is a beta-lactamase inhibitor. It blocks the resistance enzymes that some bacteria produce, which allows the antibiotic to carry on working against them.
Must not be used by patients with a known allergy to cefpodoxime or to the cephalosporin group of antibiotics. Must not be used by patients who have had cholestatic jaundice or liver dysfunction linked to clavulanic acid combinations. Check with a doctor first if the patient has a history of penicillin allergy, as cross-allergy with cephalosporins may occur. Check with a doctor first if the patient has liver disease. Check with a doctor first during pregnancy or breastfeeding.
Odoxicef CV WFR Dry Syrup is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner